Growth

HMG.

Available Variants

75 IU

View lab reports Quality process

Research area: Growth

🛡️

For research purposes only. Not intended for use in humans or animals.

GH-axis research

About HMG

HMG is among the peptides researched in the context of the growth hormone (GH) axis. The FSH component acts on Sertoli cells, complementing the LH-mediated action of HCG and addressing both sides of the testicular signaling axis.

Research Application

Studied in reproductive research, where the FSH component complements the LH-mediated action of HCG, addressing both sides of the testicular or ovarian signaling axis.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

Content 75 IU

Form Lyophilized powder

Category Growth

Purity & Identity see lab reports →

Sequence / Structure Combination of FSH and LH activity (approx. 1:1), extracted from postmenopausal urine

Regulatory Status First introduced clinically in 1961; over 60 years of use in reproductive medicine. Approved as a pharmaceutical product (e.g. Menopur, Repronex).

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Numerous preclinical and some clinical studies exist on the GH axis, with evidentiary strength varying by substance.

Muir CA, et al. Clin Endocrinol. 2024. PMID 39445789
Lunenfeld B. Hum Reprod Update. 2004;10(6):453–467.

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Question about HMG?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram

← Back to overview